Law ❯ Corporate Law ❯ Securities Regulation

False Statements

Investor Protection Legal Claims Legal Compliance Material Misrepresentation Investor Damages Market Misrepresentation Market Misconduct Ready Capital Allegations Investor Claims New Drug Application Misleading Information SEC Enforcement

Driven Brands Investors Face May 8 Deadline in Securities Suit Over Accounting Restatements

Law firms are recruiting shareholders to seek lead-plaintiff status after the company said past financial statements could not be relied upon.

ImmunityBio Faces Growing Securities Suits After FDA Flags Misleading Anktiva Claims

ImmunityBio Sued in Securities Class Action Over Anktiva Marketing Claims

Eos Energy Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Richtech Robotics Faces Wave of Securities Suits Over Microsoft Claims as Lead Plaintiff Deadline Nears

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

DeFi Technologies Securities Class Action Faces Jan. 30 Lead‑Plaintiff Deadline

Fermi Faces SDNY Securities Class Action Over IPO Disclosures as March 6 Lead-Plaintiff Deadline Nears

Klarna IPO Investors Pressed to Seek Lead Role in Credit-Risk Suit as Feb. 20 Deadline Nears

Bitdeer Investors Face Feb. 2 Deadline in Securities Class Action Over SEAL04 Disclosures

Law Firms Seek F5 Investors Before Feb. 17 Lead-Plaintiff Deadline in Securities Suit Over 2025 Breach

SLM Securities Class Action Enters Lead-Plaintiff Phase Ahead of Feb. 17 Deadline

CarMax Securities Suit Enters Lead-Plaintiff Phase as Jan. 2 Deadline Nears

Skye Bioscience Hit With Securities Class Action Over Nimacimab Disclosures as Firms Court Lead Plaintiff

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures

Savara Securities Case Nears Lead‑Plaintiff Deadline as Firms Court Investors